Author:
Esposito Katherine,Chiodini Paolo,Capuano Annalisa,Maiorino Maria Ida,Bellastella Giuseppe,Giugliano Dario
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference24 articles.
1. D.R. Whiting, L. Guariguata, C. Weil, J. Shaw, IDF Diabetes Atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res. Clin. Pract. 94, 311–321 (2011)
2. A.S. Go, D. Mozaffarian, V.L. Roger et al., On behalf of the American Heart Association Statistics Committee an Stroke Statistics Subcommittee. Heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation 127, e6–e245 (2013)
3. K. Esposito, A. Ceriello, D. Giugliano, Does personalized diabetology overcome clinical uncertainty and therapeutic inertia in type 2 diabetes? Endocrine (2013). doi: 10.1007/s12020-013-9918-x
4. T. Karagiannis, P. Paschos, K. Paletas, D.R. Matthews, A. Tsapas, Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis. BMJ 344, e1369 (2013)
5. Y. Takeda, Y. Fujita, J. Honjo, T. Yanagimachi, H. Sakagami, Y. Takiyama, Y. Makino, A. Abiko, T.J. Kieffer, M. Haneda, Reduction of both beta cell death and alpha cell proliferation by dipeptidyl peptidase-4 inhibition in a streptozotocin-induced model of diabetes in mice. Diabetologia 55, 404–412 (2012)
Cited by
45 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献